Pharmacogenomics offers an opportunity to help shield female cardiology patients from some of the negative impacts by helping to streamline the process from diagnosis to finding a successful treatment for that patient.
The post Pharmacogenomics Can Help Buffer Female Cardiac Patients From Impacts Of Funding Cuts appeared first on MedCity News.
